Vaccine Production Capacity on the Rise in China as COVID-19 Inoculations Increase

BEIJING--April 12, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--The COVID-19 pandemic has sparked a sharp rise in China's vaccine production, as the country seeks to protect its citizens and export its vaccines abroad.

So far, the domestic use of China's self-produced COVID-19 vaccine has exceeded 150 million doses, and the export volume has exceeded 100 million doses. The China Vaccine Industry Association revealed that COVID-19 vaccine capacity is expected to reach 5 billion doses next year. The production is strictly controlled by the state.